Saturday, January 22, 2022
Cumberland Pharmaceuticals, Inc.’s (NASDAQ: CPIX) Caldolor Pain Reliever Receives FDA Approval for Pre-Operation Administration
Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) is engaged as a specialty pharmaceutical company, which is focused on development and delivery of...
Read more
Krystal Biotech, Inc. (NASDAQ: KRYS) Reports Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK to Treat Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. (NASDAQ: KRYS) is engaged as a gene therapeutics company, which is focused on the research, development and...
Read more
Pasithea Therapeutics Corp. (NASDAQ: KTTA) Shares Skyrocket After Approval to Offer Esketamine Nasal Spray at its U.K. Clinics
Pasithea Therapeutics Corp. (NASDAQ: KTTA) is engaged as a U.S.-based biotechnology company, which is focused on the research, development and...
Read more
iSpecimen, Inc. (NASDAQ: ISPC) Announces Agreement with U.S. Government and Private Researchers to Supply Human Biospecimens for Advanced COVID-19 Research
iSpecimen, Inc. (NASDAQ: ISPC) is engaged as an online marketplace for human biospecimens. Seeking to connect life scientists with healthcare...
Read more
Longeveron, Inc. (NASDAQ: LGVN) Shares Skyrocket 175% After U.S. FDA Approves Lomecel-B for Rare Pediatric Disease Designation
Longeveron, Inc. (NASDAQ: LGVN) is engaged as a clinical-stage biotechnology company, which is specifically focused on the research, development and...
Read more
BIMI International Medical, Inc. (NASDAQ: BIMI) Reports Third Quarter 2021 Revenue Growth of 345%, Shares Surge over 50%
BIMI International Medical, Inc. (NASDAQ: BIMI) is engaged as a healthcare products and services provider, which operates four key segments:...
Read more
Unity Biotechnology, Inc. (NASDAQ: UBX) Provides Update on UBX1325 Clinical Studies, Releases Third Quarter Financial Results
Unity Biotechnology, Inc. (NASDAQ: UBX) is engaged in the research, testing and development of novel therapeutics to slow, halt or...
Read more
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) Sees STENDRA Sales Surge 476% Year-over-Year Due to Hims & Hers Health, Inc. (NYSE: HIMS) Collaboration
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is engaged as a specialized men’s health company, which is focused on the research, development,...
Read more
HCW Biologics, Inc. (NASDAQ: HCWB) Shares Soar After FDA Provided Clearance for HCW9218’s Phase 1b Clinical Trial for Treatment of Pancreatic Cancer
HCW Biologics, Inc. (NASDAQ: HCWB) is engaged as a biotechnology company, which is primarily focused on the research, discovery and...
Read more
Inspira Technologies (NASDAQ: IINN) Enters into Strategic Agreement with Waas Group to Send 1,040 ART Systems Across Spain and Portugal
Inspira Technologies (NASDAQ: IINN) is engaged as an Israeli medical device company, which focuses on research, development and commercialization of...
Read more
